Cargando…
Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries
INTRODUCTION: The presence of N-nitrosamine impurities in medicines raised concerns globally as they are genotoxic and probable human carcinogens. A review of N-nitrosamine impurities in medicines provides an opportunity for National Regulatory Authorities (NRAs) to ensure that corrective and preven...
Autores principales: | Shabangu, Patience P., Kuwana, Rutendo J., Dube, Admire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500151/ https://www.ncbi.nlm.nih.gov/pubmed/36160156 http://dx.doi.org/10.3389/fmed.2022.975032 |
Ejemplares similares
-
Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative
por: Sithole, Tariro, et al.
Publicado: (2020) -
Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022) -
Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022) -
Presence of Nitrosamine Impurities in Medicinal Products
por: Sedlo, Ilijana, et al.
Publicado: (2021) -
The EU Response to the Presence of Nitrosamine Impurities in Medicines
por: Ruepp, Robin, et al.
Publicado: (2021)